- Home
- PYPD vs CREX Comparison
PYPD vs CREX Comparison
Compare PYPD & CREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- CREX
- Stock Information
- Founded
- PYPD 2008
- CREX N/A
- Country
- PYPD Israel
- CREX United States
- Employees
- PYPD N/A
- CREX N/A
- Industry
- PYPD Medical/Dental Instruments
- CREX EDP Services
- Sector
- PYPD Health Care
- CREX Technology
- Exchange
- PYPD Nasdaq
- CREX Nasdaq
- Market Cap
- PYPD 34.8M
- CREX 35.2M
- IPO Year
- PYPD 2020
- CREX N/A
- Fundamental
- Price
- PYPD $3.37
- CREX $2.40
- Analyst Decision
- PYPD Strong Buy
- CREX Strong Buy
- Analyst Count
- PYPD 5
- CREX 1
- Target Price
- PYPD $12.00
- CREX $6.00
- AVG Volume (30 Days)
- PYPD 71.2K
- CREX 67.6K
- Earning Date
- PYPD 08-13-2025
- CREX 08-13-2025
- Dividend Yield
- PYPD N/A
- CREX N/A
- EPS Growth
- PYPD N/A
- CREX N/A
- EPS
- PYPD N/A
- CREX N/A
- Revenue
- PYPD N/A
- CREX $48,218,000.00
- Revenue This Year
- PYPD N/A
- CREX $4.96
- Revenue Next Year
- PYPD N/A
- CREX $21.73
- P/E Ratio
- PYPD N/A
- CREX N/A
- Revenue Growth
- PYPD N/A
- CREX N/A
- 52 Week Low
- PYPD $2.30
- CREX $1.28
- 52 Week High
- PYPD $3.93
- CREX $4.85
- Technical
- Relative Strength Index (RSI)
- PYPD 48.80
- CREX 41.58
- Support Level
- PYPD $3.35
- CREX $2.44
- Resistance Level
- PYPD $3.56
- CREX $2.72
- Average True Range (ATR)
- PYPD 0.16
- CREX 0.19
- MACD
- PYPD 0.00
- CREX 0.02
- Stochastic Oscillator
- PYPD 65.56
- CREX 36.21
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About CREX Creative Realities Inc.
Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.